Citigroup Upgrades Agilon Health to Neutral, Raises Price Target to $115
Benzinga Newsdesk 2 months ago
NewsUpgradesAnalyst RatingsPrice Target
Citigroup analyst Daniel Grosslight upgrades Agilon Health (NYSE:AGL) from Sell to Neutral and raises the price target from $105 to $115.
Citigroup analyst Daniel Grosslight upgrades Agilon Health (NYSE:AGL) from Sell to Neutral and raises the price target from $105 to $115.